Your provider can help set expectations and determine whether treatment remains appropriate based on your medical history, symptoms, and follow-up review
The rising appeal of GLP-1 drugs for cosmetic weight loss has led to a significant increase in off-label prescribing, which can result in unnecessary claims, legal or ethical dilemmas and the risk of poor health outcomes for individuals who may not receive the right support for their condition
Some anti-emetics have the potential for KEG Q-Tc prolongation, as do some other drugs used for the treatment of gastroparetic symptoms
In turn, the late-phase allergic response is triggered by leukotriene B4 (LTB4), neutrophil chemotactic factor (NCF), eosinophil chemotactic factor of anaphylaxis (ECF-A), and PAF
The gastrointestinal effects of these medicationsslowed stomach emptying and reduced appetiterequire careful assessment when inflammatory bowel disease is present